Yıldırım Yusuf, Alagöz Cengiz, Demir Abdülvahit, Ölçücü Onur, Özveren Mehmet, Ağca Alper, Özgürhan Engin Bilge, Demirok Ahmet
Prof. Dr. N. Reşat Belger Beyoğlu Eye Training and Research Hospital, İstanbul, Turkey.
Kağıthane State Hospital, Ophthalmology Clinic, İstanbul, Turkey.
Turk J Ophthalmol. 2016 Oct;46(5):200-204. doi: 10.4274/tjo.22605. Epub 2016 Oct 17.
To evaluate two-year results of small-incision lenticule extraction (SMILE) for correction of high myopia.
Forty-five eyes of 35 patients with mean spherical equivalent (SE) of -7.10±0.95 D who underwent routine SMILE by a single surgeon and were followed for at least 2 years were analyzed by retrospective chart review. SMILE was performed with a Visumax femtosecond laser (Carl Zeiss Meditec, Jena, Germany). Follow-up intervals were at 1, 6, 12, and 24 months after surgery. Uncorrected and best corrected distance visual acuity (CDVA), corneal wavefront measurements, and all complications were recorded.
After 2 years, 86% of eyes with plano target had an uncorrected distant visual acuity (VA) of 20/20 or better. Two percent of eyes lost 1 line of CDVA, while 32% gained 1 line. The mean SE after 2 years was -0.30±0.50 D. Corneal total high-order aberrations (HOA) increased from 0.43 to 0.92 μm at postoperative 12 months. There were metallic foreign bodies at the corneal interface in 1 eye of 1 patient which caused no decrease in VA.
SMILE for high myopia seems safe and effective in light of two-year follow-up results. The procedure caused a moderate increase in HOA.
评估小切口透镜切除术（SMILE）矫正高度近视的两年效果。
通过回顾性病历审查，分析了35例患者的45只眼，这些患者平均等效球镜度（SE）为-7.10±0.95 D，由一名外科医生进行常规SMILE手术，并随访至少2年。使用Visumax飞秒激光（德国耶拿卡尔蔡司医疗技术公司）进行SMILE手术。术后随访时间为1、6、12和24个月。记录未矫正和最佳矫正远视力（CDVA）、角膜波前测量结果以及所有并发症。
两年后，目标屈光度为平光的眼中，86%的未矫正远视力（VA）达到20/20或更好。2%的眼睛CDVA下降1行，而32%的眼睛CDVA提高1行。两年后的平均SE为-0.30±0.50 D。术后12个月时，角膜总高阶像差（HOA）从0.43增加到0.92μm。1例患者的1只眼中角膜界面有金属异物，未导致视力下降。
根据两年的随访结果，SMILE治疗高度近视似乎安全有效。该手术导致HOA适度增加。
